Source: BioPharma Dive

ObsEva: Women's health company Obseva to wind down, lay off staff

The company is still attempting to "monetize" its most advanced drug, a treatment to aid pregnancy via in vitro fertilization.

Read full article »
Annual Revenue
$5.0-25M
Employees
1-25
Fabien de Ladonchamps's photo - CEO of ObsEva

CEO

Fabien de Ladonchamps

CEO Approval Rating

82/100

Read more